Dr. Giulia Gramignano, winner of the selection process, has been appointed director of the oncology department at San Gavino Monreale Hospital.

For ASL General Director Joseph Polimeni, this milestone marks a decisive turning point: "I am deeply pleased with the return of a truly effective leadership figure to lead such a crucial department, moving beyond the temporary (acting) position. Oncology is a fundamental pillar of the San Gavino Hospital's organizational chart and the entire medical department. The appointment of Dr. Giulia Gramignano is not a final destination, but rather the first step in a broader plan to reorganize the medical and hospital management of the area."

The facility receives an average of over 500 new oncology patients each year. Approximately 10,000 admissions and services were recorded at the hospital in 2025 alone. In 2025, a 40 percent rate of active outpatient mobility from other local health authorities was achieved. Furthermore, 70 percent of follow-up visits (follow-ups and initial visits) were successfully transferred from the hospital to the community thanks to the community outreach project launched between 2018 and 2024.

"Today," adds ASL General Director Joseph Polimeni, "oncology is no longer just about chemotherapy, radiotherapy, or surgery. There are many other innovative methods, such as immunotherapy and targeted therapy. We will increasingly move toward personalized medicine. This appointment is the first in a long series of changes to the organizational chart and organizational structures of our management, both hospital and regional," continues Joseph Polimeni. "One of the critical issues I've encountered so far has been the extreme lack of coverage in top management roles. This is the first competition, but we're already ready for the others."

The Hospital-Territory Oncology Complex Unit of the Medio Campidano Local Health Authority, part of the Medical Area Department, represents a cutting-edge model capable of integrating hospital care, community services, and palliative care. The unit has developed a skills-based organization, where each oncologist is responsible for specific tumor pathologies and works within multidisciplinary corporate and inter-corporate teams.